DOCSLIB.ORG

Medical Conditions and Driving

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Medical Conditions and Driving Medical Conditions and Driving: A Review of the Literature (1960 – 2000) Technical Report Documenta tion Page 1. Report No. 2. Government Accession No. 3. Recipient's Catalog No. DOT HS 809 690 4. Title and Subtitle 5. Report Date Medical Conditions and Driving: A Review September 2005 of the Scientific Literature (1960 - 2000) 6. Performing Organization Code 7. Author(s) 8. Performing Organization Report No. Bonnie M. Dobbs, Ph.D. 9. Performing Organization Name and Address 10. Work Unit No. (TRAIS) Association for the Advancement of Automotive Medicine P.O. Box 4176 Barrington, Illinois 60011-4176 11. Contract or Grant No. DTNH22-94-G-05297 12. Sponsoring Agency Name and Address 13. Type of Report and Period Covered U.S. Department of Transportation National Highway Traffic Safety Administration Office of Research and Technology 400 Seventh Street, SW. Washington, DC 20590 14. Sponsoring Agency Code 15. Supplementary Notes Dr. John Eberhard served as the NHTSA Contracting Officer's Technical Representative for the study. Ms. Elaine (Petrucelli) Wodzin of the Association for the Advancement of Automotive Medicine served as the Project Principal Investigator. Drs. Maria Vegega (NHTSA) and Bonnie Dobbs completed the final report. 16. Abstract: This report reviews the contribution of medical conditions and functional limitations (e.g., sensory, motor, or cognitive functioning) to motor vehicle crashes. It provides a comprehensive and up-to-date review of the international research literature on the effects of medical and functional conditions on driving performance. The report is divided into 15 sections (Introduction, Vision, Hearing, Cardiovascular Diseases, Cerebrovascular Diseases, Peripheral Vascular Diseases, Diseases of the Nervous System, Respiratory Diseases, Metabolic Diseases, Renal Diseases, Muscuoloskeletal Disabilities, Psychiatric Diseases, Drugs, The Aging Driver, and the Effects of Anesthesia and Surgery). Each section contains a brief overview of the condition/illness; prevalence information; a review of the medical, gerontological, and epidemiological literature relevant to the condition/illness, followed by current fitness to drive guidelines for the condition/illness from Canada and Australia. The Appendix presents preliminary guidelines for physicians to assess medical fitness-to-drive. The report is a scholarly but practical compendium that can serve as a valuable resource for physicians, rehabilitation practitioners, other allied health care professionals and educators, Department of Motor Vehicle personnel, road and traffic safety personnel, transportation planners, highway safety researchers, and public policymakers. Its value is particularly relevant as the driving population increases in size and age. 17. Key Words 18. Distribution Statement Medical conditions, functional ability, older driver No restrictions. This document is available to the safety, physician guidelines to driving. public through the National Technical Information Service, Springfield, VA 22161. 19. Security Classif. (of this report) 20. Security Classif.(of this page) 21. No. of Pages 22. Price Unclassified Unclassified Form DOT F 1700.7 (8-72) Repro duction of completed p age autho rized A Review of the Scientific Literature Foreword Acknowledgements This report provides a comprehensive review The author is indebted to a number of of past and current research on the effects of individuals who made this report possible. medical conditions on driving performance. It Dr. David Carr, Dr. John Eberhard, Dr. Richard is divided into 15 sections (Introduction, Marottoli, Ms. Maureen Malinkowski, Dr. Vision, Hearing, Cardiovascular Diseases, Germaine Odenheimer, Dr. Desmond O’Neill, Cerebrovascular Diseases, Peripheral Vascular Dr. Robert Raleigh, and Ms. Elaine (Petrucelli) Diseases, Diseases of the Nervous System, Wodzin reviewed drafts of the report and Respiratory Diseases, Metabolic Diseases, contributed to the development of the prelim- Renal Diseases, Muscuoloskeletal Disabilities, inary guidelines for physicians. Sincere Psychiatric Diseases, Drugs, The Aging Driver, thanks and appreciation are extended to them and The Effects of Anesthesia and Surgery). for their time, effort, and assistance on this Each section provides a brief overview of the project. Appreciation also is extended to the condition/illness; prevalence information; Canadian Medical Association and Austroads review of the medical, gerontological, and for allowing the reproduction of their fitness- epidemiological literature relevant to medical to-drive guidelines. Many thanks go to the conditions and driving; followed by current Association for the Advancement of fitness to drive guidelines from Australia and Automotive Medicine (AAAM) and the Canada for the condition/illness. An National Highway Traffic Safety appendix contains preliminary guidelines Administration (NHTSA) for providing developed to assist physicians in determining funding for this project. Finally, the author when patients have medical conditions that recognizes Elaine Wodzin for her support and can affect fitness-to-drive. encouragement during the life of this project. This report is a scholarly but practical Bonnie M. Dobbs, Ph.D. compendium that can serve as a valuable University of Alberta resource for physicians, rehabilitation practi- Edmonton, Alberta, Canada tioners, other allied health care professionals and educators, Department of Motor Vehicle personnel, road and traffic safety personnel, transportation planners, highway safety researchers, and public policymakers. Its value is particularly relevant as the driving population increases in size and age. i Medical Conditions and Driving: ii A Review of the Scientific Literature Section 8: Respiratory Diseases . .75 Table of Contents 8.1 Asthma . .75 Section Page 8.2 Chronic Obstructive Pulmonary Disease . .75 Section 1: Introduction . .1 8.3 Other Pulmonary Conditions . .77 Section 2: Vision . .4 Section 9: Metabolic Diseases . .80 2.1 Acuity 9.1 Diabetes Mellitus . .80 2.1a. Static Visual Acuity . .4 9.2 Thyroid Disease . .88 2.1b. Dynamic Visual Acuity . .5 9.2a. Hyperthyroidism . .88 2.1c. Low Vision and Telescopic Lens . .5 9.2b. Hypothyroidism . .88 2.2 Cataracts . .5 2.3 Color Vision Defects . .6 Section 10: Renal Diseases . .93 2.4 Contrast Sensitivity . .7 10.1 Chronic Renal Failure . .93 2.5 Diabetic Retinopathy . .7 10.2 End Stage Renal Disease . .93 2.6 Glaucoma . .8 2.7 Loss of Vision in One Eye (Monocular Vision) . .9 Section 11: Musculoskeletal Disabilities . .96 2.8 Macular Degeneration . .9 2.9 Nystagmus . .10 Section 12: Psychiatric Diseases . .102 2.10 Night Myopia . .10 2.11 Post-Eye Surgery . .11 Section 13: Drugs . .109 2.12 Visual Field Defects . .11 13.1 Antidepressants . .109 13.2 Antihistamines . .111 Section 3: Hearing . .19 13.3 Benzodiazepines . .112 Section 4: Cardiovascular Diseases . .22 Section 14: The Aging Driver . .115 4.1 Coronary Artery/Heart Disease . .22 14.1 Sensory Decline . .115 4.2 Disturbances of Cardiac Rhythm . 25 14.2 Motor Decline . .116 4.2a. Ventricular Arrhythmias . .25 14.3 Cognitive Decline . .116 4.2b. Atrial Fibrillation/Flutter . .26 14.4 Dementia . .117 4.2c. Heart Block . .27 4.2d. Pacemakers . .27 Section 15: The Effects of Anesthesia and Surgery . .126 4.2e. Implantable Cardioverter/ 15.1 General Anesthesia . .126 Defibrillator Devices (ICDs) . .27 15.2 Outpatient Surgery . .126 4.3 Congestive Heart Failure . .30 15.3 Major Surgery . .128 4.4 Abnormal Blood Pressure . .31 4.4a. Hypertension . .31 4.4b. Hypotension . .32 Appendix A: Preliminary Guidelines for Physicians: Assessing Medical Section 5: Cerebrovascular Diseases . .39 5.1 Transient Ischemic Attacks . .39 Fitness to Drive (June 2000) . .130 5.2 Cerebrovascular Accidents . .39 Section 1: Introduction . .131 Section 6: Peripheral Vascular Diseases . .56 Section 2: Vision . .132 Section 7: Diseases of the Nervous System . .58 7.1 Syncope . .58 Section 3: Hearing . .134 7.2 Seizures . .58 7.3 Sleep Disorders . .62 Section 4: Cardiovascular Diseases . .135 7.3a. Narcolepsy . .62 7.3b. Sleep Apnea . .64 Section 5: Cerebrovascular Diseases . .138 Section 6: Peripheral Vascular Diseases . .139 iii Medical Conditions and Driving: Section 7: Diseases of the Nervous System . Table 11 Summary of Studies Assessing Fitness-to- 140 Drive in Individuals Post-CVA . .42 Section 8: Respiratory Diseases . 142 Section 9: Metabolic Diseases . .143 Table 12 Summary of Studies Assessing the Psycho- metric Properties of Fitness-to-Drive Section 10: Renal Diseases . .144 Evaluations in Patients Suffering from Cerebrovascular Accidents . .47 Section 11: Musculoskeletal Disabilities . .145 Table 13 Guidelines for Cerebrovascular Diseases . .52 Section 12: Psychiatric Diseases . .147 Table 14 Guidelines for Peripheral Vascular Diseases . 56 Section 13: Drugs . .148 Table 15 Classification System of Epileptic Seizures Section 14: The Aging Driver . .150 as Advanced by the Commission on Section 15: The Effects of Anesthesia and Surgery . .151 Classification and Terminology of the International League Against Epilepsy . .59 Section 16: Conditions under Investigation . .151 Table 16 Summary of Studies Examining the Risk of Section 17: Miscellaneous Conditions . .151 Crash for Individuals With Epilepsy . .60 List of Tables Page Table 17 Summary of Studies Examining the Relationship Between Crashes and Table 1 Guidelines for Visual Conditions/Diseases .12 Narcolepsy, and Simulator Performance and Narcolepsy . .63 Table 2 Estimate of the Prevalence
Load more

Recommended publications
  • HUD Consolidated Plan
    2018 – 2022 CONSOLIDATED PLAN CITY OF BELLINGHAM, WASHINGTON (covering the period from July 1, 2018 – June 30, 2023) May 29, 2018 This version of the Bellingham Consolidated Plan uses the organization and tables required by HUD’s Integrated Disbursement and Information System (IDIS). For a more user-friendly document, please view the Public version of the Consolidated Plan draft, published simultaneously, and available in the same locations as this version (online, at the Planning Department, and in the Bellingham Library branches). Please contact the Community Development Division, Department of Planning & Community Development, at [email protected] with any questions or comments, or visit http://www.cob.org. Consolidated Plan BELLINGHAM 1 OMB Control No: 2506-0117 (exp. 06/30/2018) This page is intentionally blank. Consolidated Plan BELLINGHAM 2 OMB Control No: 2506-0117 (exp. 06/30/2018) Table of Contents Executive Summary ....................................................................................................................................... 6 ES-05 Executive Summary - 24 CFR 91.200(c), 91.220(b) ......................................................................... 6 The Process ................................................................................................................................................. 12 PR-05 Lead & Responsible Agencies 24 CFR 91.200(b) ........................................................................... 12 PR-10 Consultation - 91.100, 91.200(b), 91.215(l) ................................................................................
    [Show full text]
  • Shifting and Seizing: a Call to Reform Ohio's Outdated Restrictions on Drivers with Epilepsy
    SHIFTING AND SEIZING: A CALL TO REFORM OHIO’S OUTDATED RESTRICTIONS ON DRIVERS WITH EPILEPSY KATHRYN KRAMER I. INTRODUCTION .................................................................... 343 II. THE MEDICAL BACKGROUND .............................................. 347 III. DISABILITIES AND STIGMA OF EPILEPSY .............................. 351 IV. THE OHIO LICENSING STATUTES ......................................... 355 V. SEISURE -RELATED ACCIDENT CASE LAW ............................ 357 VI. PROBLEMS WITH THE APPLICATION .................................... 359 A. Basic Intent of the Statues Has Failed......................... 359 B. Unnecessary Imposition of Negligence upon Clearing Physicians............................................ 361 C. Abuse of Police Power................................................. 363 1. Over-Inclusive...................................................... 363 2. Under-Inclusive.................................................... 365 3. Undue Burden....................................................... 366 VII. CHANGES IN APPLICATION ................................................... 368 A. Three-Month Mandated Suspension of Driving Privileges........................................................ 368 B. Physician Immunity for Good-Faith Certifications............................................................... 369 C. Negligence Standard for Drivers with Epilepsy.......... 370 D. Subjective Approach.................................................... 371 VIII. CONCLUSION .......................................................................
    [Show full text]
  • Approach to Acute Ataxia in Childhood: Diagnosis and Evaluation Lalitha Sivaswamy, MD
    FEATURE Approach to Acute Ataxia in Childhood: Diagnosis and Evaluation Lalitha Sivaswamy, MD opsoclonus myoclonus ataxia syndrome, must receive special mention because the underlying disease process may be ame- nable to surgical intervention. In the tod- dler- and school-age groups, certain condi- tions (such as stroke and acute cerebellitis) require immediate recognition and imag- ing, whereas others (such as post-infec- tious ataxia and concussion) require close follow-up. Finally, mention must be made of diseases outside of the central nervous system that can present with ataxia, such as Guillain-Barré syndrome. he word ataxia is derived from the Greek word ataktos, which T means “lack of order.” Ataxia is characterized by disturbances in the voluntary coordination of posture and movement. In children, it is most prominent during walking (the sine qua non being a staggering gait with impaired tandem), but it can also be present during sitting or standing, or © Shutterstock when the child is performing move- Abstract Lalitha Sivaswamy, MD, is Associate Profes- ments of the arms, legs, or eyes. sor of Pediatrics and Neurology, Department Ataxia refers to motor incoordination that is This review focuses on the etiol- of Neurology, Wayne State University School of usually most prominent during movement ogy and diagnostic considerations for Medicine; and Medical Director, Headache Clinic, or when a child is attempting to maintain a acute ataxia, which for the purposes of Children’s Hospital of Michigan. sitting posture. The first part of the review this discussion refers to ataxia with a Address correspondence to: Lalitha Sivas- focuses on the anatomic localization of symptom evolution time of less than wamy, MD, Department of Neurology, Wayne ataxia — both within the nervous system 72 hours.1 State University School of Medicine, Children’s and without — using a combination of his- Motor coordination requires sensory Hospital of Michigan, 3901 Beaubien, Detroit, MI torical features and physical findings.
    [Show full text]
  • Scientific Opinion
    SCIENTIFIC OPINION ADOPTED: DD Month YEAR doi:10.2903/j.efsa.20YY.NNNN 1 Evaluation of the health risks related to the 2 presence of cyanogenic glycosides in foods other than raw 3 apricot kernels 4 5 EFSA Panel on Contaminants in the Food Chain (CONTAM), 6 Margherita Bignami, Laurent Bodin, James Kevin Chipman, Jesús del Mazo, Bettina Grasl- 7 Kraupp, Christer Hogstrand, Laurentius (Ron) Hoogenboom, Jean-Charles Leblanc, Carlo 8 Stefano Nebbia, Elsa Nielsen, Evangelia Ntzani, Annette Petersen, Salomon Sand, Dieter 9 Schrenk, Christiane Vleminckx, Heather Wallace, Diane Benford, Leon Brimer, Francesca 10 Romana Mancini, Manfred Metzler, Barbara Viviani, Andrea Altieri, Davide Arcella, Hans 11 Steinkellner and Tanja Schwerdtle 12 Abstract 13 In 2016, the EFSA CONTAM Panel published a scientific opinion on the acute health risks related to 14 the presence of cyanogenic glycosides (CNGs) in raw apricot kernels in which an acute reference dose 15 (ARfD) of 20 µg/kg bw was established for cyanide (CN). In the present opinion, the CONTAM Panel 16 concluded that this ARfD is applicable for acute effects of CN regardless the dietary source. Estimated 17 mean acute dietary exposures to cyanide from foods containing CNGs did not exceed the ARfD in any 18 age group. At the 95th percentile, the ARfD was exceeded up to about 2.5-fold in some surveys for 19 children and adolescent age groups. The main contributors to exposures were biscuits, juice or nectar 20 and pastries and cakes that could potentially contain CNGs. Taking into account the conservatism in 21 the exposure assessment and in derivation of the ARfD, it is unlikely that this estimated exceedance 22 would result in adverse effects.
    [Show full text]
  • Alcohol Sensitivity As an Endophenotype of Alcohol Use Disorder: Exploring Its Translational Utility Between Rodents and Humans
    brain sciences Review Alcohol Sensitivity as an Endophenotype of Alcohol Use Disorder: Exploring Its Translational Utility between Rodents and Humans Clarissa C. Parker 1,*, Ryan Lusk 2 and Laura M. Saba 2,* 1 Department of Psychology and Program in Neuroscience, Middlebury College, Middlebury, VT 05753, USA 2 Department of Pharmaceutical Sciences, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA; [email protected] * Correspondence: [email protected] (C.C.P.); [email protected] (L.M.S.) Received: 3 September 2020; Accepted: 9 October 2020; Published: 13 October 2020 Abstract: Alcohol use disorder (AUD) is a complex, chronic, relapsing disorder with multiple interacting genetic and environmental influences. Numerous studies have verified the influence of genetics on AUD, yet the underlying biological pathways remain unknown. One strategy to interrogate complex diseases is the use of endophenotypes, which deconstruct current diagnostic categories into component traits that may be more amenable to genetic research. In this review, we explore how an endophenotype such as sensitivity to alcohol can be used in conjunction with rodent models to provide mechanistic insights into AUD. We evaluate three alcohol sensitivity endophenotypes (stimulation, intoxication, and aversion) for their translatability across human and rodent research by examining the underlying neurobiology and its relationship to consumption and AUD. We show examples in which results gleaned from rodents are successfully integrated with information from human studies to gain insight in the genetic underpinnings of AUD and AUD-related endophenotypes. Finally, we identify areas for future translational research that could greatly expand our knowledge of the biological and molecular aspects of the transition to AUD with the broad hope of finding better ways to treat this devastating disorder.
    [Show full text]
  • Mechanisms of Ethanol-Induced Cerebellar Ataxia: Underpinnings of Neuronal Death in the Cerebellum
    International Journal of Environmental Research and Public Health Review Mechanisms of Ethanol-Induced Cerebellar Ataxia: Underpinnings of Neuronal Death in the Cerebellum Hiroshi Mitoma 1,* , Mario Manto 2,3 and Aasef G. Shaikh 4 1 Medical Education Promotion Center, Tokyo Medical University, Tokyo 160-0023, Japan 2 Unité des Ataxies Cérébelleuses, Service de Neurologie, CHU-Charleroi, 6000 Charleroi, Belgium; [email protected] 3 Service des Neurosciences, University of Mons, 7000 Mons, Belgium 4 Louis Stokes Cleveland VA Medical Center, University Hospitals Cleveland Medical Center, Cleveland, OH 44022, USA; [email protected] * Correspondence: [email protected] Abstract: Ethanol consumption remains a major concern at a world scale in terms of transient or irreversible neurological consequences, with motor, cognitive, or social consequences. Cerebellum is particularly vulnerable to ethanol, both during development and at the adult stage. In adults, chronic alcoholism elicits, in particular, cerebellar vermis atrophy, the anterior lobe of the cerebellum being highly vulnerable. Alcohol-dependent patients develop gait ataxia and lower limb postural tremor. Prenatal exposure to ethanol causes fetal alcohol spectrum disorder (FASD), characterized by permanent congenital disabilities in both motor and cognitive domains, including deficits in general intelligence, attention, executive function, language, memory, visual perception, and commu- nication/social skills. Children with FASD show volume deficits in the anterior lobules related to sensorimotor functions (Lobules I, II, IV, V, and VI), and lobules related to cognitive functions (Crus II and Lobule VIIB). Various mechanisms underlie ethanol-induced cell death, with oxidative stress and Citation: Mitoma, H.; Manto, M.; Shaikh, A.G. Mechanisms of endoplasmic reticulum (ER) stress being the main pro-apoptotic mechanisms in alcohol abuse and Ethanol-Induced Cerebellar Ataxia: FASD.
    [Show full text]
  • Nineteen Hundred Fifty-Two. Sixtieth Annual Report of the City of Laconia
    XltbgralHrts fflxt TtLtttbtr&itp NINETEEN HUNDRED FIFTY -TWO + + + Sixtieth Annual Report of the CITY OF LACONIA NEW HAMPSHIRE for the Year Ending June 30, 1953 UNDER THE ADMINISTRATIONS OF Honorable Robinson W. Smith, Mayor and Councilmen Leo G. Roux NAUCURAL ADDRESS OF THE Honorable Gerard L Morin Thank you Mayor Smith, Members of the Clergy, Invited Guests, Members of the Outgoing Council, Members of the Board of Education, Gentlemen of the Council, Ladies and Gentlemen. In the exercise of your power and right of self-government, you have committed to me, one of your fellow citizens, a supreme and sacred trust —and I dedicate myself to your service. There is no legal requirement that the Mayor take the oath of office in the presence of the people, but I feel it is appropriate that the people of Laconia be invited to witness this solemn ceremonial. It affects a tie—a sort of convenant between the people of Laconia and its chief executive. I convenant to serve the whole body of our citizenry by a faithful execution of the duties of a Mayor as prescribed by law. Thus, my promise is spoken—yours un- spoken, but nevertheless real and solemn. May Almighty God give me wisdom, strength and fidelity. Let us pause for a moment in memory of those individuals who have, in the past, rendered public service—have unselfishly given of their time r and who have passed away during the past tw o years : George R. Bow- man, John O'Connor, Frederick Brockington, Perley Avery, William Kempton, Max Chertok, Albert R.
    [Show full text]
  • As Writers of Film and Television and Members of the Writers Guild Of
    July 20, 2021 As writers of film and television and members of the Writers Guild of America, East and Writers Guild of America West, we understand the critical importance of a union contract. We are proud to stand in support of the editorial staff at MSNBC who have chosen to organize with the Writers Guild of America, East. We welcome you to the Guild and the labor movement. We encourage everyone to vote YES in the upcoming election so you can get to the bargaining table to have a say in your future. We work in scripted television and film, including many projects produced by NBC Universal. Through our union membership we have been able to negotiate fair compensation, excellent benefits, and basic fairness at work—all of which are enshrined in our union contract. We are ready to support you in your effort to do the same. We’re all in this together. Vote Union YES! In solidarity and support, Megan Abbott (THE DEUCE) John Aboud (HOME ECONOMICS) Daniel Abraham (THE EXPANSE) David Abramowitz (CAGNEY AND LACEY; HIGHLANDER; DAUGHTER OF THE STREETS) Jay Abramowitz (FULL HOUSE; MR. BELVEDERE; THE PARKERS) Gayle Abrams (FASIER; GILMORE GIRLS; 8 SIMPLE RULES) Kristen Acimovic (THE OPPOSITION WITH JORDAN KLEEPER) Peter Ackerman (THINGS YOU SHOULDN'T SAY PAST MIDNIGHT; ICE AGE; THE AMERICANS) Joan Ackermann (ARLISS) 1 Ilunga Adell (SANFORD & SON; WATCH YOUR MOUTH; MY BROTHER & ME) Dayo Adesokan (SUPERSTORE; YOUNG & HUNGRY; DOWNWARD DOG) Jonathan Adler (THE TONIGHT SHOW STARRING JIMMY FALLON) Erik Agard (THE CHASE) Zaike Airey (SWEET TOOTH) Rory Albanese (THE DAILY SHOW WITH JON STEWART; THE NIGHTLY SHOW WITH LARRY WILMORE) Chris Albers (LATE NIGHT WITH CONAN O'BRIEN; BORGIA) Lisa Albert (MAD MEN; HALT AND CATCH FIRE; UNREAL) Jerome Albrecht (THE LOVE BOAT) Georgianna Aldaco (MIRACLE WORKERS) Robert Alden (STREETWALKIN') Richard Alfieri (SIX DANCE LESSONS IN SIX WEEKS) Stephanie Allain (DEAR WHITE PEOPLE) A.C.
    [Show full text]
  • Epilepsy and Employment
    SYSTEM NAVIGATION Epilepsy and Employment Can I be fired because of my epilepsy? • Installing a safety shield around a piece of Both federal and provincial human rights codes machinery. prevent employers from firing someone because they • Installing a piece of carpet to cover a concrete have a diagnosis of epilepsy. However, employers floor in the employee’s work area. sometimes use other reasons to mask a discriminatory termination. • Putting work instructions in writing (rather than just giving them orally) if memory What are my rights if I am fired because of a difficulties/deficits are a side effect of the seizure seizure? disorder or anti-seizure medication. If you think you’ve lost your job because of your • Scheduling consistent work shifts if seizure epilepsy, whether or not your employer admits to it, activity is made worse by inconsistent sleep you have the right to use the Human Rights complaint patterns. process. Contact your community epilepsy agency for • Allowing an employee who experiences fatigue as guidance or the Office of the Ontario Human Rights a side effect of medication the place and Commission. opportunity to take frequent rest breaks. • Allowing an employee to take time off to recover What kind of accommodations should my after a seizure. employer make? Some people with epilepsy don’t require any For help with accommodation, contact your accommodations at work, while others may require community epilepsy agency at 1-866-EPILEPSY (1-866- accommodations to help them avoid triggers, ensure 374-5377). There are extensive resources for they can remain safe if they have a seizure while on employers about accommodations at the job, or help them adapt to seizure or medication www.epilepsyatwork.com.
    [Show full text]
  • The Firs' of A
    . _ BTainin , Paul it.; k Others St%idy, on Dri v ng by S '1 Popu ns. Al Report, Volume 'Conduct .of' the-_ .ect,and State ,=of the Art. Tm_sTippTior. DunlapaniA'ssociates, nc.,Darieff, Conn;. SP.ONS AGENCY Bureau of Educationfor the Handicapped (DH.E.W/:0E)*. Washington,(Lit'. Na jo al Highyay Tra ffic safety Administration (DOT) , Waghington, FEPORT SO DOT-.-HS7802 329 PUB DATE . Apr77, CONTRACT__ DOTT.HS-..701206` 10T? 167p..:. Frpr relatedinfor AVAILABLE F Nat-ion e.1 TechnicalInform- EDPS PPICE MFO 1/PC07' Plus- Pogta-g-a. DESCRIPTORS .Aurally'Handicapped:Cerebral Pal ..1-1 -0i7seas4.5: *Driver rcillcation; Emotionally Disturbed; FP1.1e.PsY; EgUiPment; Evaluaton Method-s;-*Handicapped; mental Tliness;' MPn4:ally t,feurologicallf - Handicappedt Physically Handicapped;.,'Special. Health Problems:- *State L'egislationts 'State iiicensitiq Boards; . - o *Traffic Safety. ., The firs' ofA -volumereporton,m.otol: veh driving by handicapped :parsons focuses, on driving behavior. f -cat 19. types of handicapping conditions. Information is deta&led,,Feg drivereducation an& assesslent materials', present ste* regarding licenSing,-relevantmedical opinion regarding licensing and .axamination, com-plicating factors (such as theuseof therapeutic4 drugs) ,and private-and commercialdriving behavior for specific -. conditions, including the following: mental retardation, mental illness, neurologic and carebrovascular handicaps, epilepsy, - diabetes., musculoskeletal handicaps,. hearingAisoriers,thyro diseasei renal disorders, cancer, and obesity. Automotive. adaptive equipmer# 'is briefly coneidered monq 12 recommeldations. made. are. for a more comprehensive analysis' of the drliving task for, normal Itivars4 'a large scalp epidemiological studyto measure the acoidan,+. .and:7:Lolation sates of sc:),cifio,haUdicapped groups, and validat-d Asse,sSnient and evaluation oroc,edurs.
    [Show full text]
  • Management of Alcohol Use Disorders: a Pocket Reference for Primary Care Providers
    Management of alcohol use disorders: A pocket reference for primary care providers Meldon Kahan, MD Edited by Kate Hardy, MSW and Sarah Clarke, PhD Acknowledgments Mentoring, Education, and Clinical Tools for Addiction: Primary Care–Hospital Integration (META:PHI) is an ongoing initiative to improve the experience of addiction care for both patients and providers. The purpose of this initiative is to set up and implement care pathways for addiction, foster mentoring relationships between addiction physicians and other health care providers, and create and disseminate educational materials for addiction care. This pocket guide is excerpted from Safe prescribing practices for addictive medications and management of substance use disorders in primary care: A pocket reference for primary care providers, a quick-reference tool for primary care providers to assist them in implementing best practices for prescribing potentially addictive medications and managing substance use disorders in primary care, endorsed by the College of Family Physicians of Canada. This excerpt is a guide to talking to patients about their alcohol use and managing at-risk drinking and alcohol use disorders. We thank those who have given feedback on this document: Dr. Mark Ben-Aron, Dr. Peter Butt, Dr. Delmar Donald, Dr. Mike Franklyn, Dr. Melissa Holowaty, Dr. Anita Srivastava, and three anonymous CFPC reviewers. We gratefully acknowledge funding and support from the following organizations: Adopting Research to Improve Care (Health Quality Ontario & Council of Academic Hospitals of Ontario) The College of Family Physicians of Canada Toronto Central Local Health Integration Network Women’s College Hospital Version date: December 19, 2017 © 2017 Women’s College Hospital All rights reserved.
    [Show full text]
  • Self-Regulatory Driving Behaviour, Perceived Abilities and Comfort Level of Older Drivers with Parkinson’S Disease Compared to Age-Matched Controls
    Self-Regulatory Driving Behaviour, Perceived Abilities and Comfort Level of Older Drivers with Parkinson’s disease compared to Age-Matched Controls by Alexander Michael Crizzle A thesis presented to the University of Waterloo in fulfillment of the thesis requirement for the degree of Doctor of Philosophy in Health Studies and Gerontology - Aging, Health and Well-Being Waterloo, Ontario, Canada, 2011 © Alexander Michael Crizzle 2011 Declaration I hereby declare that I am the sole author of this thesis. This is a true copy of the thesis, including any required final revisions, as accepted by my examiners. I understand that my thesis may be made electronically available to the public. ii Abstract Introduction: Multiple studies have shown the symptoms of Parkinson‟s disease (PD) can impair driving performance. Studies have also found elevated crash rates in drivers with PD, however, none have controlled for exposure or amount of driving. Although a few studies have suggested that drivers with PD may self-regulate (e.g., by reducing exposure or avoiding challenging situations), findings were based on self-report data. Studies with healthy older drivers have shown that objective driving data is more accurate than self-estimates. Purposes: The primary objectives of this study were to examine whether drivers with PD restrict their driving (exposure and patterns) relative to an age-matched control group and explore possible reasons for such restrictions: trip purposes, perceptions of driving comfort and abilities, as well as depression, disease severity and symptoms associated with PD. Methods: A convenience sample of 27 drivers with PD (mean 71.6±6.6, range 57 to 82, 78% men) and 20 age-matched control drivers from the same region (70.6±7.9, range 57 to 84, 80% men) were assessed between October 2009 and August 2010.
    [Show full text]